[The effective of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in hypersomnia and subcortical dementia caused by bilateral medial thalamic and midbrain infarcts].
D000368:Aged; D002544:Cerebral Infarction / Q000150:complications*; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D006970:Disorders of Excessive Somnolence / Q000188:drug therapy* / Q000209:etiology; D015103:Droxidopa / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008636:Mesencephalon / Q000098:blood supply*; D012694:Serine / Q000031:analogs & derivatives*; D012893:Sleep Wake Disorders / Q000188:drug therapy*; D013788:Thalamus / Q000098:blood supply*
D012694:Serine; D015103:Droxidopa